September 30th, 2011
written by Michael O’Leary
While looking to find harmful effects of type 2 diabetes drugs on the heart and cardiovascular system, researchers were surprised to find that at least one class of these drugs appear to actually help prevent such effects.
As reported on by MedPage Today at the European Association for the Study of Diabetes meeting last week in Lisbon, Portugal, the researchers found that the class of drugs, called gliptins, were associated with 30 percent reduction in the risk of a major heart-related event, such as a heart attack, compared to diabetes patients who were taking another drug or placebo.
In the wake of the development of heart-related side effects of a cancer drug, called Avandia, last year, the FDA required drug companies to assess the cardiovascular risks of some of the new diabetes drugs. (Link to published site)